HDL and adaptive immunity: A tale of lipid rafts

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 34-35

  Norata, Giuseppe Danilo ^a,b,c   Catapano, Alberico Luigi ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale Bassini   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d IRCCS MULTIMEDICA   (Italy)

Author keywords

HDL; Immunity

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PENTRAXIN 3;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; MACROPHAGE; MONOCYTE; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; APOLIPOPROTEIN A-I; LIPOPROTEINS, HDL; MEMBRANE MICRODOMAINS; T-LYMPHOCYTES;

EID: 84867880949     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.08.020     Document Type: Note

References (9)

1. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000, 1:156-162.
2. Norata G.D., Pirillo A., Ammirati E., Catapano A.L. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 2012, 220:11-21.
3. Zilber M.T., Setterblad N., Vasselon T., et al. MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes. Blood 2005, 106:3074-3081.
4. Wang S.H., Yuan S.G., Peng D.Q., et al. HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. Atherosclerosis 2012, 225(1):105-114.
5. Voight B.F., Peloso G.M., Orho-Melander M., et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012.
6. Collet X., Marcel Y.L., Tremblay N., et al. Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure. J Lipid Res 1997, 38:634-644.
7. Hansson G.K., Bjorkholm M. Medicine. Tackling two diseases with HDL. Science 2010, 328:1641-1642.
8. Norata G.D., Marchesi P., Pirillo A., et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol 2008, 28:925-931.
9. Yvan-Charvet L., Pagler T., Gautier E.L., et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010, 328:1689-1693.